Back

NAVER D2SF invests in ImpriMed’s $10 million AI healthcare funding round

Verifying
  • NAVER D2SF invested in ImpriMed’s $10 million Series A2 bridge financing round.
  • $10 million funded ImpriMed’s AI precision-medicine expansion into human healthcare.
  • ImpriMed plans FDA clearance and CLIA certification by the first quarter of 2027.
The information on this website is generated using AI and we cannot guarantee its accuracy. Please use it as reference information only.